Etrasimod Uses, Dosage, Side Effects and more
Etrasimod is under investigation in clinical trial NCT03945188 (Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis).
| Attribute | Details |
|---|---|
| Trade Name | Etrasimod |
| Generic | Etrasimod |
| Etrasimod Other Names | Etrasimod |
| Type | |
| Formula | C26H26F3NO3 |
| Weight | Average: 457.493 Monoisotopic: 457.18647819 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
